[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:ovarian-endometrioid-adenocarcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"Ovarian Endometrioid Adenocarcinoma",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06321484","Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer",[11],"Phase 1","RECRUITING","2026-08-26T02:18:08.005333Z","2026-07-05T05:32:16.754624Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06690775","CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.",[19],"Phase 2","2026-08-26T02:19:03.581490Z","2026-05-05T02:43:28.216661Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT07690189","Study of NTB-928 in R\u002FR OC",[11],"2026-08-26T02:17:04.346841Z","2026-07-19T19:36:05.156065Z",[],[]]